Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
17/06/2021
15/06/2021
03/06/2021
31/05/2021
31/05/2021
17/05/2021
14/05/2021
15/04/2021
09/04/2021
31/03/2021
23/03/2021
19/03/2021
15/03/2021
10/03/2021
03/03/2021
03/03/2021
25/02/2021
19/02/2021
19/02/2021
17/02/2021
22/02/2021
27/01/2021
25/01/2021
15/01/2021
14/01/2021
04/01/2021
24/12/2020
21/12/2020
17/12/2020
15/12/2020
15/12/2020